K

Kathryn M. Monroe

Denali Therapeutics (United States)

ORCID: 0000-0002-6901-1176

58 papers and 8.2k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

🌱#1 Emerging Leader in Apelin-related biomedical research 🌱#1 Emerging Leader in Inflammation biomarkers and pathways

58Publications

8.2kTotal Citations

#1in Apelin-related biomedical research

First publication: 1992First senior author: 2020

Top publicationsby citations

A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models

Bettina van Lengerich, Kathryn M. Monroe|Nature Neuroscience|2023

Cited by 217

Indexing the rest of 58 publications…